RESMED CDI (Australia) Today


AUD 33.94  0.28  0.83%   

Market Performance
4 of 100
Odds Of Distress
Less than 24
RESMED CDI is trading at 33.94 as of the 26th of November 2022; that is 0.83 percent up since the beginning of the trading day. The stock's open price was 33.66. RESMED CDI has about a 24 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for RESMED CDI 101 are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of December 2020 and ending today, the 26th of November 2022. Click here to learn more.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. RESMED CDI operates under Medical Instruments Supplies classification in Australia and is traded on Australian Securities Exchange. The company has 1.46 B outstanding shares. More on RESMED CDI 101
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

RESMED CDI Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. RESMED CDI's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding RESMED CDI or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOMichael Farrell
Thematic IdeaHealthcare (view all)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of RESMED CDI's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
RESMED CDI 101 (RMD) is traded on Australian Securities Exchange in Australia and employs 8,160 people. The company currently falls under 'Large-Cap' category with current market capitalization of 48.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate RESMED CDI's market, we take the total number of its shares issued and multiply it by RESMED CDI's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. RESMED CDI 101 operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 1.46 B outstanding shares. RESMED CDI 101 has accumulated about 273.71 M in cash with 351.15 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47.
Check RESMED CDI Probability Of Bankruptcy
RESMED CDI 101 has a total of 1.46 Billion outstanding shares. Roughly 92.0 pct. of RESMED CDI outstanding shares are held by regular investors with 0.0 % owned by insiders and only 8.37 (%) by third-party entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check RESMED Ownership Details

RESMED Stock Price Odds Analysis

Based on a normal probability distribution, the odds of RESMED CDI jumping above the current price in 90 days from now is about 45.34%. The RESMED CDI 101 probability density function shows the probability of RESMED CDI stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon RESMED CDI has a beta of 0.0089 indicating as returns on the market go up, RESMED CDI average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding RESMED CDI 101 will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. RESMED CDI 101 is significantly underperforming DOW.
  Odds Below 33.94HorizonTargetOdds Above 33.94
54.26%90 days
Based on a normal probability distribution, the odds of RESMED CDI to move above the current price in 90 days from now is about 45.34 (This RESMED CDI 101 probability density function shows the probability of RESMED Stock to fall within a particular range of prices over 90 days) .

RESMED CDI 101 Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. RESMED CDI market risk premium is the additional return an investor will receive from holding RESMED CDI long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in RESMED CDI. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although RESMED CDI's alpha and beta are two of the key measurements used to evaluate RESMED CDI's performance over the market, the standard measures of volatility play an important role as well.

RESMED Stock Against Markets

Picking the right benchmark for RESMED CDI stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in RESMED CDI stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for RESMED CDI is critical whether you are bullish or bearish towards RESMED CDI 101 at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in RESMED CDI without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Tickers Now


Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

RESMED CDI Corporate Directors

RESMED CDI corporate directors refer to members of a RESMED CDI board of directors. The board of directors generally takes responsibility for the RESMED CDI's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of RESMED CDI's board members must vote for the resolution. The RESMED CDI board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
John Wareham - Independent DirectorProfile
Ronald Taylor - Lead Independent DirectorProfile
Gary Pace - Independent DirectorProfile
Agnes Lee - Senior Director - Investor RelationsProfile

Invested in RESMED CDI 101?

The danger of trading RESMED CDI 101 is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of RESMED CDI is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than RESMED CDI. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile RESMED CDI 101 is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, take a look at Your Equity Center. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for analysis

When running RESMED CDI 101 price analysis, check to measure RESMED CDI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RESMED CDI is operating at the current time. Most of RESMED CDI's value examination focuses on studying past and present price action to predict the probability of RESMED CDI's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move RESMED CDI's price. Additionally, you may evaluate how the addition of RESMED CDI to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Please note, there is a significant difference between RESMED CDI's value and its price as these two are different measures arrived at by different means. Investors typically determine RESMED CDI value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RESMED CDI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.